These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19443805)

  • 1. Recombinant T cell receptor ligand treats experimental stroke.
    Subramanian S; Zhang B; Kosaka Y; Burrows GG; Grafe MR; Vandenbark AA; Hurn PD; Offner H
    Stroke; 2009 Jul; 40(7):2539-45. PubMed ID: 19443805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.
    Dziennis S; Mader S; Akiyoshi K; Ren X; Ayala P; Burrows GG; Vandenbark AA; Herson PS; Hurn PD; Offner HA
    Metab Brain Dis; 2011 Jun; 26(2):123-33. PubMed ID: 21472429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke.
    Pan J; Palmateer J; Schallert T; Hart M; Pandya A; Vandenbark AA; Offner H; Hurn PD
    Transl Stroke Res; 2014 Oct; 5(5):577-85. PubMed ID: 24838614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.
    Benedek G; Zhu W; Libal N; Casper A; Yu X; Meza-Romero R; Vandenbark AA; Alkayed NJ; Offner H
    Metab Brain Dis; 2014 Mar; 29(1):37-45. PubMed ID: 24122483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.
    Zhu W; Dotson AL; Libal NL; Lapato AS; Bodhankar S; Offner H; Alkayed NJ
    Neuroscience; 2015 Mar; 288():112-9. PubMed ID: 25556831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke.
    Zhu W; Casper A; Libal NL; Murphy SJ; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2015 Feb; 6(1):60-8. PubMed ID: 25270354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.
    Wang J; Ye Q; Xu J; Benedek G; Zhang H; Yang Y; Liu H; Meza-Romero R; Vandenbark AA; Offner H; Gao Y
    Transl Stroke Res; 2017 Jun; 8(3):284-293. PubMed ID: 27988839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
    Zhu W; Libal NL; Casper A; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2014 Oct; 5(5):612-7. PubMed ID: 24953050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.
    Akiyoshi K; Dziennis S; Palmateer J; Ren X; Vandenbark AA; Offner H; Herson PS; Hurn PD
    Transl Stroke Res; 2011 Sep; 2(3):404-10. PubMed ID: 21961027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.
    Offner H; Subramanian S; Parker SM; Wang C; Afentoulis ME; Lewis A; Vandenbark AA; Hurn PD
    J Immunol; 2006 Jun; 176(11):6523-31. PubMed ID: 16709809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice.
    Jin R; Zhu X; Liu L; Nanda A; Granger DN; Li G
    Stroke; 2013 Apr; 44(4):1135-43. PubMed ID: 23391769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.
    Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke.
    Xiao W; Guo S; Chen L; Luo Y
    J Neuroimmunol; 2019 Aug; 333():576970. PubMed ID: 31146104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke.
    Goebel S; Li Z; Vogelmann J; Holthoff HP; Degen H; Hermann DM; Gawaz M; Ungerer M; Münch G
    PLoS One; 2013; 8(7):e66960. PubMed ID: 23935828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide preconditioning increased the level of regulatory B cells in the spleen after acute ischaemia/reperfusion in mice.
    Wang Z; Zhou Y; Yu Y; He K; Cheng LM
    Brain Res; 2018 Dec; 1701():46-57. PubMed ID: 29803621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
    Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y
    Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG.
    Sinha S; Subramanian S; Emerson-Webber A; Lindner M; Burrows GG; Grafe M; Linington C; Vandenbark AA; Bernard CC; Offner H
    J Neuroimmune Pharmacol; 2010 Jun; 5(2):231-9. PubMed ID: 19789980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.